|
Name |
Tetratriacontane
|
Molecular Formula | C34H70 | |
IUPAC Name* |
tetratriacontane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
|
|
InChI |
InChI=1S/C34H70/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-34H2,1-2H3
|
|
InChIKey |
GWVDBZWVFGFBCN-UHFFFAOYSA-N
|
|
Synonyms |
Tetratriacontane; N-TETRATRIACONTANE; 14167-59-0; 94UA0738YX; NSC-2998; n-Tetratriacontane 100 microg/mL in Hexane; Tetratriacontane, analytical standard; UNII-94UA0738YX; NSC 2998; EINECS 238-013-0; Tetratriacontane, 98%; AI3-36492; DTXSID7058622; CHEBI:87443; NSC2998; ZINC6920424; BBL103832; LMFA11000587; MFCD00009412; STL557642; AKOS025212369; AS-57006; DB-042580; CS-0315160; FT-0637022; T0687; T2938; T71761; Q151145; J-007535; FF7BB6B8-4684-449E-9BAA-3CEDC172E786
|
|
CAS | 14167-59-0 | |
PubChem CID | 26519 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 478.9 | ALogp: | 18.0 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 31 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 34 | QED Weighted: | 0.069 |
Caco-2 Permeability: | -5.613 | MDCK Permeability: | 0.00000133 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.031 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 104.18% |
Volume Distribution (VD): | 6.065 | Fu: | 0.49% |
CYP1A2-inhibitor: | 0.017 | CYP1A2-substrate: | 0.104 |
CYP2C19-inhibitor: | 0.078 | CYP2C19-substrate: | 0.048 |
CYP2C9-inhibitor: | 0.006 | CYP2C9-substrate: | 0.984 |
CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.007 |
CYP3A4-inhibitor: | 0.095 | CYP3A4-substrate: | 0.006 |
Clearance (CL): | 4.14 | Half-life (T1/2): | 0.002 |
hERG Blockers: | 0.543 | Human Hepatotoxicity (H-HT): | 0.002 |
Drug-inuced Liver Injury (DILI): | 0.525 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.008 | Maximum Recommended Daily Dose: | 0.06 |
Skin Sensitization: | 0.986 | Carcinogencity: | 0.01 |
Eye Corrosion: | 0.998 | Eye Irritation: | 0.922 |
Respiratory Toxicity: | 0.111 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000438 | 0.971 | D00AOJ | 0.590 | ||||
ENC000381 | 0.940 | D00STJ | 0.390 | ||||
ENC000437 | 0.910 | D07ILQ | 0.368 | ||||
ENC000443 | 0.880 | D00FGR | 0.367 | ||||
ENC000436 | 0.850 | D0Z1QC | 0.350 | ||||
ENC000541 | 0.847 | D01NTX | 0.345 | ||||
ENC000435 | 0.820 | D0Z5SM | 0.328 | ||||
ENC001705 | 0.813 | D06KDP | 0.310 | ||||
ENC001204 | 0.812 | D05ZPL | 0.298 | ||||
ENC000401 | 0.790 | D0T9TJ | 0.294 |